Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
December 17, 2018
ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of ...
December 17, 2018
OSE Immunotherapeutics Appoints Julien Perrier Chief Commercial Officer
NANTES, France, Dec. 17, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA(ISIN: FR0012127173; Mnémo: OSE) today announced the appointment of Julien Perrier as chief commercial officer. ...
December 17, 2018
Transgene Announces Financial Calendar for 2019
STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News: Transgene (TNG.PA) today announced its financial reporting dates for 2019: March 20: 2018 Fiscal Year Results May 13:  First Quarter ...
December 11, 2018
BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
TEL AVIV, Israel, Dec. 11, 2018 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today the initiation ...
December 11, 2018
Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses
JERUSALEM, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (ENTX) announced today that it has entered into a research collaboration and license agreement with ...
December 11, 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer™ as Published in JACC
VANCOUVER, Dec. 11, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
December 11, 2018
STRATA Skin Sciences Secures Exclusive License for Treating Vitiligo Using an Excimer Laser
HORSHAM, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
December 11, 2018
Cellectar Granted Japanese Patent for CLR 131
FLORHAM PARK, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
December 11, 2018
BELLUS Health Announces Pricing of $35 Million Public Offering of Common Shares
LAVAL, Quebec, Dec. 11, 2018 (GLOBE NEWSWIRE) -- BELLUS Health Inc. (BLU.TO) (BELLUS Health or the Company), a clinical-stage biopharmaceutical company developing novel therapeutics for ...
December 11, 2018
RedHill Biopharma Announces Closing of $20 Million Underwritten Offering
TEL-AVIV, Israel and RALEIGH, N.C., Dec. 11, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
December 11, 2018
Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer
Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that its global ...
December 11, 2018
Eiger BioPharmaceuticals Reports on 2018 R&D Day
PALO ALTO, Calif., Dec. 11, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today ...
December 11, 2018
Arrowhead Pharmaceuticals Reports Fiscal 2018 Year End Results
Arrowhead Pharmaceuticals Inc. (ARWR) today announced financial results for its fiscal 2018 fourth quarter and year ended September 30, 2018. The company is hosting a ...
December 11, 2018
Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency
AUSTIN, Texas, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
December 6, 2018
Kuros Reports Publication of MagnetOs Data Demonstrating Equivalence to Autologous Bone in Spinal Fusion
SCHLIEREN (ZURICH), Switzerland, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) today announced the publication of data from a clinically-relevant preclinical model comparing MagnetOs ...
December 6, 2018
Abivax receives DSMB recommendation to continue ongoing extension study of its completed phase 2a clinical trial in ulcerative colitis patients
PARIS--(BUSINESS WIRE)-Abivax (ABVX.PA) (Euronext Paris: FR0012333284 – ABVX), a biotechnology company harnessing the immune system to develop treatments for inflammatory/autoimmune diseases, infectious diseases and cancer, ...
December 6, 2018
BioLineRx to Host Investor and Analyst Breakfast Meeting on December 11, 2018 in New York
TEL AVIV, Israel, December 6, 2018 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX.TA), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it ...
December 6, 2018
Athenex to Host an R&D Day on December 17 in New York
BUFFALO, N.Y., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
December 6, 2018
Spring Bank Pharmaceuticals Hosts R&D Day on Pipeline of Novel Immunomodulatory Therapeutics
HOPKINTON, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
December 6, 2018
Aimmune Therapeutics to Host Investor Symposium on the Future of Treating Peanut Allergy with Leading Expert Allergists on Wednesday, December 12th
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that it will host an Investor Symposium in ...
Page 11 of 128